Table 2.
Individual Quality Indicator Outcomes by HIV Care Models
| Total, n = 1565 | Outcome | ID n = 875 | Generalist n = 90 | ID Plus Generalist n = 600 | P Value* |
|---|---|---|---|---|---|
| Process | |||||
| Retention (%) | 96.0 | 100 | 99.3 | <.0001 | |
| CD4 test (%) | 82.4 | 85.6 | 81.8 | .53 | |
| Screening | |||||
| Chlamydia (%) | 79.4 | 78.9 | 79.8 | .74 | |
| Tuberculosis (%) | 80.9 | 82.2 | 81.5 | .36 | |
| Hepatitis B (%) | 94.9 | 96.7 | 94.3 | .70 | |
| Hepatitis C (%) | 95.0 | 85.6 | 95.0 | .31 | |
| Immunization | |||||
| Influenza (%) | 89.1 | 87.8 | 91.7 | .27 | |
| Pneumonia (%) | 85.7 | 82.2 | 87.5 | .16 | |
| (n = 667) | Hepatitis B (%) | 76.2 | 61.5 | 74.8 | .21 |
| HIV management | |||||
| (n = 108) | PCP prophylaxis (%) | 82.1 | 100 | 87.5 | .32 |
| (n = 538) | ART (CD4 <500) (%) | 90.3 | 84.9 | 94.2 | .15 |
| (n = 1153) | VL suppression (%) | 91.4 | 86.4 | 91.9 | .67 |
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; ID, infectious disease; PCP, Pneumocystis jiroveci pneumonia; SD, standard deviation; VL, viral load.
* P values testing overall differences among the 3 groups.